NasdaqCM - Delayed Quote USD

Envoy Medical, Inc. (COCH)

6.63 +0.13 (+2.00%)

At close: October 30 at 4:00:00 PM EDT

Envoy Medical Updates Third Quarter 2026 Earnings Call Time to 8:00 A.M. ET on Thursday, November 5th

TMX Newsfile 4d ago

COCH
+2.00%
Envoy Medical Announces Reverse Stock Split

TMX Newsfile 10d ago

COCH
+2.00%
Envoy Medical Hits Six-Month Milestone, Marks Halfway Point in Final Stage of Data Collection, and Highlights Differentiated Device Design

TMX Newsfile 12d ago

COCH
+2.00%
Envoy Medical Submits Second Module of Modular Premarket Approval Application to FDA for Breakthrough Designated Acclaim(R) Cochlear Implant

TMX Newsfile 20d ago

COCH
+2.00%
Envoy Medical Announces New Patents, Further Expanding Global Patent Portfolio

TMX Newsfile 1mo ago

COCH
+2.00%
Envoy Medical to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14th-16th

TMX Newsfile 1mo ago

COCH
+2.00%
Envoy Medical, Inc. (COCH) Reports Q2 Loss, Misses Revenue Estimates

Zacks 2mo ago

COCH
+2.00%
ELMD
Envoy Medical Surpasses Three-Month Visit Milestone for All 56 Patients in Pivotal Clinical Trial

TMX Newsfile 3mo ago

COCH
+2.00%
EXCLUSIVE: Envoy Medical Hits Key Clinical Trial Milestone for Fully Implanted Ear Implant

Benzinga 3mo ago

COCH
+2.00%
Envoy Medical Reports Positive 12-Month Data Showing Continued Improvement in Speech Perception in Study of First-of-Its-Kind Fully Implanted Cochlear Implant

TMX Newsfile 3mo ago

COCH
+2.00%
EXCLUSIVE: Envoy Medical Builds Momentum With Improved Cochlear Implant Trial Results

Benzinga 3mo ago

COCH
+2.00%
Envoy Medical Submits First Module of Modular Premarket Approval Application to the U.S. Food and Drug Administration for Breakthrough-Designated Device

TMX Newsfile 4mo ago

COCH
+2.00%

U.S. markets closed

Envoy Medical, Inc. (COCH)

Envoy Medical Updates Third Quarter 2026 Earnings Call Time to 8:00 A.M. ET on Thursday, November 5th

Envoy Medical Announces Reverse Stock Split

Envoy Medical Hits Six-Month Milestone, Marks Halfway Point in Final Stage of Data Collection, and Highlights Differentiated Device Design

Envoy Medical Submits Second Module of Modular Premarket Approval Application to FDA for Breakthrough Designated Acclaim(R) Cochlear Implant

Envoy Medical Announces New Patents, Further Expanding Global Patent Portfolio

Envoy Medical to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14th-16th

Envoy Medical, Inc. (COCH) Reports Q2 Loss, Misses Revenue Estimates

Envoy Medical Surpasses Three-Month Visit Milestone for All 56 Patients in Pivotal Clinical Trial

EXCLUSIVE: Envoy Medical Hits Key Clinical Trial Milestone for Fully Implanted Ear Implant

Envoy Medical Reports Positive 12-Month Data Showing Continued Improvement in Speech Perception in Study of First-of-Its-Kind Fully Implanted Cochlear Implant

EXCLUSIVE: Envoy Medical Builds Momentum With Improved Cochlear Implant Trial Results

Envoy Medical Submits First Module of Modular Premarket Approval Application to the U.S. Food and Drug Administration for Breakthrough-Designated Device